These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4083974)

  • 41. Netilmicin use in pediatric patients.
    Chindasilpa V; Schauf V; Hamilton LR; Riff LJ
    Dev Pharmacol Ther; 1980; 1(4):238-53. PubMed ID: 7438970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Kinetics of tobramycin in newborn infants in intensive care].
    Guillois B; Guedes Y; Le Guen E; Le Bot MA; Riche C; Alix D
    Pathol Biol (Paris); 1986 May; 34(5):346-8. PubMed ID: 3534704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.
    Kearns GL; Young RA; Jacobs RF
    Clin Pharmacokinet; 1992 Apr; 22(4):284-97. PubMed ID: 1606788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of plasma levels of amoxicillin administered by oral and intravenous routes in neonatal bacterial colonization].
    Autret E; Laugier J; Marimbu J; Vaillant MC; Furet Y; Breteau M
    Arch Fr Pediatr; 1988 Nov; 45(9):679-82. PubMed ID: 3233058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of intravenous clindamycin in newborn infants.
    Koren G; Zarfin Y; Maresky D; Spiro TE; MacLeod SM
    Pediatr Pharmacol (New York); 1986; 5(4):287-92. PubMed ID: 3737273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic evaluation of cimetidine in newborn infants.
    Stile IL; Simon R; Hiatt IM; Hegyi T
    Clin Ther; 1985; 7(3):361-4. PubMed ID: 3995530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of the intravenous route for the use of phenobarbital in asphyxiated full term newborn infants].
    Gold F; Bourin M; Granry JC; Amine A; Breteau M; Laugier J
    Arch Fr Pediatr; 1979 Jun; 36(6):610-6. PubMed ID: 526116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics.
    Kafetzis DA; Brater DC; Kapiki AN; Papas CV; Dellagrammaticas H; Papadatos CJ
    J Pediatr; 1982 Mar; 100(3):483-9. PubMed ID: 6278118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of cefotaxime in newborn infants.
    McCracken GH; Threlkeld NE; Thomas ML
    Antimicrob Agents Chemother; 1982 Apr; 21(4):683-4. PubMed ID: 6282216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmacokinetic, bacteriological and clinical studies of cefotaxime in newborn and immature infants].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Takajo N; Araki H; Imai S; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Hashimoto T; Nakajima H; Matsuo H; Imuta F
    Jpn J Antibiot; 1982 Jul; 35(7):1819-45. PubMed ID: 6294363
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in neonates.
    Crooks J; White LO; Burville LJ; Speidel BD; Reeves DS
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():97-101. PubMed ID: 6094467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses.
    Neu HC; Aswapokee P; Fu KP; Ho I; Matthijssen C
    Clin Pharmacol Ther; 1980 May; 27(5):677-85. PubMed ID: 6245831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Examination of blood levels and urinary excretion of cefmetazole in the mature and immature neonates (author's transl)].
    Nanri S; Sunakawa K; Yamashita N; Akita H; Hotta M; Ichihashi Y; Ishikawa K; Okazaki K; Kanemitsu T; Ri S
    Jpn J Antibiot; 1981 Jun; 34(6):874-9. PubMed ID: 6945447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetic studies on parenteral infusion of tobramycin in newborn and premature infants].
    Toyonaga Y; Sugita M; Kurosu Y; Hori M
    Jpn J Antibiot; 1983 Oct; 36(10):2856-68. PubMed ID: 6674521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Basic and clinical studies on the use of cefotaxime in neonates].
    Toyonaga Y; Kurosu Y; Sugita M; Hori M
    Jpn J Antibiot; 1982 Jul; 35(7):1767-82. PubMed ID: 6294358
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacokinetics of ceftazidime in children and newborn infants. Study in 14 patients and review of the literature].
    Quinet B; Bégué P
    Presse Med; 1988 Oct; 17(37):1921-4. PubMed ID: 2973586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous immunoglobulin for prophylaxis or treatment of bacterial infection in neonates.
    Christensen RD
    J Perinatol; 1987; 7(1):58-61. PubMed ID: 3333793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Intravenous-intramuscular bioequivalency of ceftriaxone in newborn infants].
    Saby MA; Guibert M; Magny JF; Praud JP; Chabernaud JL; Dehan M; Gabilan JC
    Arch Fr Pediatr; 1987 Oct; 44(8):615-7. PubMed ID: 3442464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical effectiveness and pharmacokinetic characteristics of cefotaxime in premature infants with pneumonia].
    Parshina NV
    Antibiot Med Biotekhnol; 1986 Apr; 31(4):298-301. PubMed ID: 3717928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.